Analytical Data
-
Gene name
TAF9
- Application
-
Alternative Names
TAF9；TAF9L；Transcription initiation factor TFIID subunit 9B
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16594
-
Expression Region
1-264aa
-
AA Sequence
MESGKTASPKSMPKDAQMMAQILKDMGITEYEPRVINQMLEFAFRYVTTILDDAKIYSSHAKKATVDADDVRLAIQCRADQSFTSPPPRDFLLDIARQRNQTPLPLIKPYSGPRLPPDRYCLTAPNYRLKSLQKKASTSAGRITVPRLSVGSVTSRPSTPTLGTPTPQTMSVSTKVGTPMSLTGQRFTVQMPTSQSPAVKASIPATSAVQNVLINPSLIGSKNILITTNMMSSQNTANESSNALKRKREDDDDDDDDDDDYDNL
-
Molecular Weight
34.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAF9 is a crucial component of the transcriptional machinery, specifically a subunit of the TFIID complex, which plays a pivotal role in the initiation of gene transcription by RNA polymerase II. Research on TAF9 has gained prominence due to its involvement in various cellular processes, including gene regulation, cell differentiation, and response to stress. Given its implications in cancer and other diseases, understanding TAF9's structure and function is essential for uncovering the molecular mechanisms of transcriptional control. Additionally, the investigation of its reconstitution as a recombinant protein allows for detailed studies of its biochemical properties and interactions with other transcription factors. This approach facilitates the exploration of TAF9’s role in transcription regulation and its potential as a therapeutic target. Recent advancements in recombinant protein technology have enabled the production of TAF9 in sufficient quantities, providing a valuable tool for both in vitro and in vivo studies. This research not only enhances our comprehension of the transcriptional regulatory networks but also opens avenues for novel therapeutic interventions in diseases linked to transcriptional dysregulation.
